626 related articles for article (PubMed ID: 15980640)
21. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.
Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A
Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
[TBL] [Abstract][Full Text] [Related]
23. Non-invasive detection of fetal rhesus D status: a comparison between polymerase chain reaction and flow cytometry.
Di Simone N; Lai M; Rumi C; Riccardi P; D'Asta M; Leone G; Mancuso S; Caruso A
Fetal Diagn Ther; 2006; 21(5):404-9. PubMed ID: 16912487
[TBL] [Abstract][Full Text] [Related]
24. [Fetal DNA in maternal blood].
Rijnders RJ; Christiaens GC; de Haas M; van der Schoot CE
Ned Tijdschr Geneeskd; 2004 Jan; 148(4):170-4. PubMed ID: 14974307
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
Kimura M; Sato C; Hara M; Ishihara O; Ikebuchi K
Transfusion; 2008 Jun; 48(6):1156-63. PubMed ID: 18422850
[TBL] [Abstract][Full Text] [Related]
26. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
Achargui S; Tijane M; Benchemsi N
Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
[TBL] [Abstract][Full Text] [Related]
27. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types.
Hyland CA; Millard GM; O'Brien H; Schoeman EM; Lopez GH; McGowan EC; Tremellen A; Puddephatt R; Gaerty K; Flower RL; Hyett JA; Gardener GJ
Pathology; 2017 Dec; 49(7):757-764. PubMed ID: 29096879
[TBL] [Abstract][Full Text] [Related]
30. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
[TBL] [Abstract][Full Text] [Related]
31. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
32. [RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible].
Orzińska A; Engel K; Łakomy M; Smolarczyk-Wodzyńska J; Lipińska A; Pelc-Kłopotowska M; Brojer E
Ginekol Pol; 2009 Oct; 80(10):786-90. PubMed ID: 19943546
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of non-invasive prenatal RHD genotyping of the fetus.
Hyland CA; Gardener GJ; Davies H; Ahvenainen M; Flower RL; Irwin D; Morris JM; Ward CM; Hyett JA
Med J Aust; 2009 Jul; 191(1):21-5. PubMed ID: 19580531
[TBL] [Abstract][Full Text] [Related]
34. Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.
Benachi A; Delahaye S; Leticee N; Jouannic JM; Ville Y; Costa JM
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):28-32. PubMed ID: 22386678
[TBL] [Abstract][Full Text] [Related]
35. [Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].
Carbonne B; Cortey A; Rouillac-Le Sciellour C; Brossard Y
Gynecol Obstet Fertil; 2008 Feb; 36(2):200-203. PubMed ID: 18243756
[TBL] [Abstract][Full Text] [Related]
36. [Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma].
Sesarini C; Giménez ML; Redal MA; Izbizky G; Aiello H; Argibay P; Otaño L
Arch Argent Pediatr; 2009 Oct; 107(5):405-9. PubMed ID: 19809760
[TBL] [Abstract][Full Text] [Related]
37. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
[TBL] [Abstract][Full Text] [Related]
39. High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spectrometry.
Grill S; Banzola I; Li Y; Rekhviashvili T; Legler TJ; Müller SP; Zhong XY; Hahn S; Holzgreve W
Arch Gynecol Obstet; 2009 Apr; 279(4):533-7. PubMed ID: 18751991
[TBL] [Abstract][Full Text] [Related]
40. Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Legler TJ
Prenat Diagn; 2011 Dec; 31(13):1300-4. PubMed ID: 22030893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
